Ricardo Chaves, n/a

Debiopharm International
Lausanne, Vaud, Switzerland

Disclosure(s): Debiopharm International S.A.: Salary

Presentation(s):

• 107 - Results from A Phase 2 Clinical Trial for Treatment of Bone And Joint Infections with Afabicin, A First-in-Class Selective Anti-Staphylococcal Antibiotic

  Thursday, October 17, 2024
  12:35 PM – 12:40 PM US PT